Bone Health ECHO Case Report: Fractures and Hypercalcemia in a Patient with Stage 5 Chronic Kidney Disease

IF 1.7 4区医学 Q4 ENDOCRINOLOGY & METABOLISM

Journal of Clinical Densitometry Pub Date : 2024-02-15 DOI:10.1016/j.jocd.2024.101478

E. Michael Lewiecki , Dale G. Erickson , Roger W. Gildersleeve

引用次数: 0

Abstract

Bone Health ECHO (Extension for Community Healthcare Outcomes) is a virtual community of practice with the aim of enhancing global capacity to deliver best practice skeletal healthcare. The prototype program, established at the University of New Mexico, has been meeting online weekly since 2015, focusing on presentation and discussion of patient cases. These discussions commonly cover issues that are relevant to a broad range of patients, thereby serving as a force multiplier to improve the care of many patients. This is a case report from Bone Health ECHO about a patient with stage 5 chronic kidney disease, hypercalcemia, and low bone density, and the discussion that followed.

查看原文本刊更多论文

骨骼健康 ECHO 病例报告：一名慢性肾病 5 期患者的骨折和高钙血症

骨健康 ECHO（Extension for Community Healthcare Outcomes）是一个虚拟实践社区，旨在提高全球提供最佳骨骼医疗服务的能力。该项目原型在新墨西哥大学建立，自 2015 年起每周举行一次在线会议，重点是介绍和讨论患者病例。这些讨论通常涉及与广大患者相关的问题，从而成为改善众多患者护理的倍增器。这是一份来自骨健康 ECHO 的病例报告，涉及一名患有慢性肾病 5 期、高钙血症和低骨密度的患者，以及随后进行的讨论。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

Journal of Clinical Densitometry 医学-内分泌学与代谢

CiteScore

4.90

自引率

8.00%

发文量

审稿时长

90 days

期刊介绍： The Journal is committed to serving ISCD''s mission - the education of heterogenous physician specialties and technologists who are involved in the clinical assessment of skeletal health. The focus of JCD is bone mass measurement, including epidemiology of bone mass, how drugs and diseases alter bone mass, new techniques and quality assurance in bone mass imaging technologies, and bone mass health/economics. Combining high quality research and review articles with sound, practice-oriented advice, JCD meets the diverse diagnostic and management needs of radiologists, endocrinologists, nephrologists, rheumatologists, gynecologists, family physicians, internists, and technologists whose patients require diagnostic clinical densitometry for therapeutic management.